Canopy Growth Corporation (CGC) Financial Ratios
17 years of historical data (2009–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
5.86
↑+294% vs avg
5yr avg: 1.49
30Y Low0.2·High37.3
ROE
↓
-61.9%
↓+31% vs avg
5yr avg: -89.1%
30Y Low-150%·High-2%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CGC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Canopy Growth Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $372M | $2.8B | $98M | $645M | $812M | $3.0B | $120.3B | $51.4B | $146.4B | $46.3B | $9.5B |
| Enterprise Value | $312M | $2.7B | $332M | $1.1B | $1.6B | $3.8B | $120.9B | $50.9B | $144.8B | $46.0B | $9.4B |
| P/E Ratio → | -1.56 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 1.85 | 9.94 | 0.36 | 2.17 | 2.44 | 6.24 | 220.14 | 128.79 | 646.72 | 594.20 | 238.61 |
| P/B Ratio | 5.86 | 4.06 | 0.20 | 1.29 | 1.07 | 0.82 | 33.23 | 14.12 | 20.21 | 37.25 | 15.48 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
CGC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 9.64 | 1.24 | 3.85 | 4.67 | 8.05 | 221.18 | 127.59 | 639.93 | 590.17 | 236.31 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
CGC Profitability
Margins and return-on-capital ratios measuring operating efficiency
Canopy Growth Corporation earns an operating margin of -56.8%. Operating margins have expanded from -77.0% to -56.8% over the past 3 years, signaling improving operational efficiency. A negative ROE of -61.9% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.5% | 24.5% | 29.6% | 27.2% | -19.1% | -39.4% | 12.2% | -7.9% | 39.3% | 95.2% | 97.0% |
| Operating Margin | -56.8% | -56.8% | -43.5% | -77.0% | -789.3% | -214.2% | -227.5% | -418.5% | -271.8% | -138.3% | -35.3% |
| Net Profit Margin | -128.8% | -128.8% | -222.4% | -221.2% | -983.7% | -65.2% | -319.2% | -331.3% | -325.3% | -86.3% | -18.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -61.9% | -61.9% | -121.1% | -104.3% | -149.7% | -8.6% | -48.1% | -24.3% | -17.4% | -7.2% | -2.0% |
| ROA | -29.6% | -29.6% | -53.9% | -35.1% | -81.5% | -5.0% | -30.0% | -19.5% | -14.5% | -6.4% | -1.8% |
| ROIC | -18.2% | -18.2% | -10.2% | -13.7% | -65.9% | -17.6% | -25.4% | -28.2% | -13.9% | -11.1% | -3.3% |
| ROCE | -15.0% | -15.0% | -12.4% | -16.9% | -74.9% | -17.1% | -22.5% | -26.0% | -12.7% | -10.8% | -3.5% |
CGC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $365M exceeds total debt of $279M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.40 | 0.40 | 0.72 | 1.33 | 1.86 | 0.45 | 0.47 | 0.12 | 0.13 | 0.01 | 0.02 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.12 | 0.48 | 0.99 | 0.98 | 0.24 | 0.16 | -0.13 | -0.21 | -0.25 | -0.15 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -5.88 | -5.88 | -7.01 | -3.47 | -23.46 | -1.58 | -68.18 | -223.70 | -33.35 | -148.20 | -101.73 |
Net cash position: cash ($365M) exceeds total debt ($279M)
CGC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Canopy Growth Corporation's current ratio of 3.34x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.64x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 1.58x to 3.34x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.34 | 3.34 | 3.12 | 1.58 | 1.34 | 8.10 | 9.98 | 6.10 | 11.95 | 5.24 | 10.12 |
| Quick Ratio | 2.64 | 2.64 | 2.10 | 1.25 | 1.24 | 7.14 | 8.68 | 5.17 | 11.49 | 3.95 | 6.68 |
| Cash Ratio | 1.67 | 1.67 | 1.39 | 0.87 | 0.96 | 6.43 | 8.15 | 4.75 | 11.04 | 3.51 | 5.76 |
| Asset Turnover | — | 0.18 | 0.29 | 0.23 | 0.14 | 0.08 | 0.08 | 0.08 | 0.03 | 0.05 | 0.06 |
| Inventory Turnover | 2.51 | 2.51 | 1.97 | 2.80 | 4.77 | 3.24 | 1.30 | 1.57 | 0.72 | 0.03 | 0.04 |
| Days Sales Outstanding | — | 46.54 | 71.62 | 63.69 | 74.98 | 66.43 | 44.81 | 57.98 | 172.51 | 100.32 | 53.20 |
CGC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Canopy Growth Corporation does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $3.0B | $108M | $75M | $46M | $39M | $376M | $356M | $338M | $177M | $119M |
Peer Comparison
Compare CGC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CGCYou | $372M | -1.6 | — | — | 24.5% | -56.8% | -61.9% | -18.2% | — |
 ACB | $181M | -1.9 | — | — | 5.2% | -50.8% | -21.8% | -25.8% | — |
 TLRY | $551M | -0.1 | — | — | 29.3% | -277.9% | -89.1% | -66.2% | — |
 CRON | $1B | -110.6 | — | 6679.1 | 32.5% | -1.5% | -0.8% | -0.7% | — |
 OGI | $136M | -9.8 | — | — | 3.7% | -34.1% | -5.4% | -17.8% | — |
 STZ | $24B | -313.7 | 9.0 | 12.6 | 51.0% | 35.5% | -0.9% | 13.0% | 3.0 |
 IIPR | $2B | 15.2 | 10.3 | 9.7 | 88.7% | 46.7% | 6.0% | 4.3% | 2.0 |
 HYFM | $4M | -0.0 | — | — | 1.6% | -29.4% | -361.3% | -12.9% | — |
 LWAY | $389M | 28.6 | 19.0 | — | 27.4% | 7.6% | 17.6% | 17.8% | 0.0 |
 SNDL | $368M | -33.6 | 8.1 | 9.0 | 27.3% | -0.5% | -1.4% | -0.3% | 3.3 |
 MAPS | $67M | 21.5 | 1.1 | 5.0 | 87.3% | 6.7% | 1.6% | 9.1% | 1.0 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 17 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
CGC — Frequently Asked Questions
Quick answers to the most common questions about buying CGC stock.
What is Canopy Growth Corporation's P/E ratio?
Canopy Growth Corporation's current P/E ratio is -1.6x. This places it at the 50th percentile of its historical range.
What is Canopy Growth Corporation's ROE?
Canopy Growth Corporation's return on equity (ROE) is -61.9%. The historical average is -38.6%.
Is CGC stock overvalued?
Based on historical data, Canopy Growth Corporation is trading at a P/E of -1.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Canopy Growth Corporation's profit margins?
Canopy Growth Corporation has 24.5% gross margin and -56.8% operating margin.